These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 37158911)

  • 41. Treatment patterns, healthcare utilization, and costs of patients with treatment-resistant depression initiated on esketamine intranasal spray and covered by US commercial health plans.
    Joshi K; Pilon D; Shah A; Holiday C; Karkare S; Zhdanava M
    J Med Econ; 2023; 26(1):422-429. PubMed ID: 36924214
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Health-related quality of life among Indian population: The EQ-5D population norms for India.
    Jyani G; Prinja S; Garg B; Kaur M; Grover S; Sharma A; Goyal A
    J Glob Health; 2023 Feb; 13():04018. PubMed ID: 36799239
    [TBL] [Abstract][Full Text] [Related]  

  • 43. EQ-5D-5L norms for the urban Chinese population in China.
    Yang Z; Busschbach J; Liu G; Luo N
    Health Qual Life Outcomes; 2018 Nov; 16(1):210. PubMed ID: 30409137
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient-reported outcomes with olaparib plus abiraterone versus placebo plus abiraterone for metastatic castration-resistant prostate cancer: a randomised, double-blind, phase 2 trial.
    Saad F; Thiery-Vuillemin A; Wiechno P; Alekseev B; Sala N; Jones R; Kocak I; Chiuri VE; Jassem J; Fléchon A; Redfern C; Kang J; Burgents J; Gresty C; Degboe A; Clarke NW
    Lancet Oncol; 2022 Oct; 23(10):1297-1307. PubMed ID: 36063830
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Quality of life profile of general Vietnamese population using EQ-5D-5L.
    Nguyen LH; Tran BX; Hoang Le QN; Tran TT; Latkin CA
    Health Qual Life Outcomes; 2017 Oct; 15(1):199. PubMed ID: 29020996
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Health-related quality of life in patients with multiple system atrophy using the EQ-5D-5L.
    Xiao Y; Zhang L; Wei Q; Ou R; Hou Y; Liu K; Lin J; Yang T; Shang H
    Brain Behav; 2022 Oct; 12(10):e2774. PubMed ID: 36124355
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effect of esketamine in patients with treatment-resistant depression with and without comorbid anxiety symptoms or disorder.
    Daly EJ; Turkoz I; Salvadore G; Fedgchin M; Ionescu DF; Starr HL; Borentain S; Trivedi MH; Thase ME; Singh JB
    Depress Anxiety; 2021 Nov; 38(11):1120-1130. PubMed ID: 34293233
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Health-related quality of life effects of enzalutamide in patients with metastatic castration-resistant prostate cancer: an in-depth post hoc analysis of EQ-5D data from the PREVAIL trial.
    Devlin N; Herdman M; Pavesi M; Phung D; Naidoo S; Beer TM; Tombal B; Loriot Y; Ivanescu C; Parli T; Balk M; Holmstrom S
    Health Qual Life Outcomes; 2017 Jun; 15(1):130. PubMed ID: 28645287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data.
    d'Andrea G; Pettorruso M; Di Lorenzo G; Rhee TG; Chiappini S; Carullo R; Barlati S; Zanardi R; Rosso G; Di Nicola M; Andriola I; Marcatili M; Clerici M; Dell'Osso BM; Sensi SL; Mansur RB; Rosenblat JD; Martinotti G; McIntyre RS
    J Affect Disord; 2024 Mar; 348():314-322. PubMed ID: 38145840
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A cross-sectional assessment of health-related quality of life in Chinese patients with chronic hepatitis c virus infection with EQ-5D.
    Huang R; Rao H; Shang J; Chen H; Li J; Xie Q; Gao Z; Wang L; Wei J; Jiang J; Sun J; Jiang J; Wei L
    Health Qual Life Outcomes; 2018 Jun; 16(1):124. PubMed ID: 29903024
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Access and real-world use patterns of esketamine nasal spray among patients with treatment-resistant depression covered by private or public insurance.
    Teeple A; Zhdanava M; Pilon D; Caron-Lapointe G; Lefebvre P; Joshi K
    Curr Med Res Opin; 2023 Aug; 39(8):1167-1174. PubMed ID: 37492015
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of Mu-Opiate Receptor Gene Polymorphism rs1799971 (A118G) on the Antidepressant and Dissociation Responses in Esketamine Nasal Spray Clinical Trials.
    Saad Z; Hibar D; Fedgchin M; Popova V; Furey ML; Singh JB; Kolb H; Drevets WC; Chen G
    Int J Neuropsychopharmacol; 2020 Dec; 23(9):549-558. PubMed ID: 32367114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Health-related quality of life during three trimesters of pregnancy in Morocco: cross-sectional pilot study.
    Boutib A; Chergaoui S; Azizi A; Saad EM; Hilali A; Youlyouz Marfak I; Marfak A
    EClinicalMedicine; 2023 Mar; 57():101837. PubMed ID: 36816344
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Health-Related Quality of Life in Cervical Dystonia Using EQ-5D-5L: A Large Cross-Sectional Study in China.
    Liang Y; Lin J; Hou Y; Zhang L; Ou R; Li C; Wei Q; Cao B; Liu K; Jiang Z; Yang T; Yang J; Zhang M; Kang S; Xiao Y; Jiang Q; Yang J; Song W; Chen X; Zhao B; Wu Y; Shang H
    Front Neurol; 2022; 13():895272. PubMed ID: 35812100
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Population norms of health-related quality of life in Moscow, Russia: the EQ-5D-5L-based survey.
    Hołownia-Voloskova M; Tarbastaev A; Golicki D
    Qual Life Res; 2021 Mar; 30(3):831-840. PubMed ID: 33237551
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dupilumab Improves General Health-Related Quality-of-Life in Patients with Moderate-to-Severe Atopic Dermatitis: Pooled Results from Two Randomized, Controlled Phase 3 Clinical Trials.
    Simpson EL
    Dermatol Ther (Heidelb); 2017 Jun; 7(2):243-248. PubMed ID: 28503712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health-Related Quality of Life and Its Related Factors in Survivors of Stroke in Rural China: A Large-Scale Cross-Sectional Study.
    Mei YX; Zhang ZX; Wu H; Hou J; Liu XT; Sang SX; Mao ZX; Zhang WH; Yang DB; Wang CJ
    Front Public Health; 2022; 10():810185. PubMed ID: 35450122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validity of EQ-5D-5L, Skindex-16, DLQI and DLQI-R in patients with hidradenitis suppurativa.
    Gergely LH; Gáspár K; Brodszky V; Kinyó Á; Szegedi A; Remenyik É; Kiss NF; Bató A; Péntek M; Gulácsi L; Sárdy M; Bánvölgyi A; Wikonkál N; Rencz F
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2584-2592. PubMed ID: 32618022
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Health-related quality of life in hepatitis C patients who achieve sustained virological response to direct-acting antivirals: a comparison with the general population.
    Juanbeltz R; Castilla J; Martínez-Baz I; O'Leary A; Sarobe M; San Miguel R
    Qual Life Res; 2019 Jun; 28(6):1477-1484. PubMed ID: 30666549
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A cross-sectional study on the determinants of health-related quality of life in the Philippines using the EQ-5D-5L.
    Cheng KJG; Rivera AS; Miguel RTDP; Lam HY
    Qual Life Res; 2021 Aug; 30(8):2137-2147. PubMed ID: 33677770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.